Scroll Back to Top
网络研讨会

在亚太地区推动建设细胞和基因治疗试验生态系统

28 May 2024
1500-1630 (KST)
Duration: 1.5 hours

Webinar Overview 

作为多学科科学舞台的前沿,细胞和基因治疗正在释放其在治疗这些无法治愈的疾病方面的潜力,从而改变患者的命运。尽管得到投资机会的助力,亚太地区的生物科技公司面临着临床操作和市场准入方面的挑战。

Join our online webinar and gain an in-depth understanding of the opportunities of cell and gene therapeutic product development and market entry strategies in this fast-evolving industry. Investigate the prospectus of operational excellence, investigator engagement, as well as patient recruitment to accelerate the journey. Additionally, explore Fortrea's solution for navigating the complexity of clinical studies in cell and gene therapy and understand the best practices in supporting the success of both emerging biotech and large pharmaceutical sponsors.

addition to the online presentations, feel free to book a seat at the actual site in Seoul, Korea, to join face-to-face discussions with Fortrea experts and key stakeholders covering the cell and gene therapy ecosystem. Share insights from various facets on advancing CGT clinical development in Asia Pacific.

Learnings

  • In-depth insights towards the evolving regulatory framework for cell and gene therapy in the US as well as the major CGT market in APAC regions.
  • Navigating the complexity in cell and gene therapy studies, leveraging resources on hospital infrastructure, clinicians, as well as chain logistics to ease the burden of investigators and sites.
  • Exploring Fortrea’s dedicated infrastructure and expertise in the CGT arena.

日程

15:00-15:15 | Landscape & Regulatory

Global CGT landscape and navigating the Regulatory Landscape

Photo of 
<span>Frederick Derosier, DO</span> Frederick Derosier, DO

Head of Rare Diseases, Advanced Therapies and Pediatrics Team (RAPT)

Dong Yang Head of Regulatory Affairs at Fortrea China

15:15-15:30 | Insights from sites

Addressing the Complexities of Conducting CGT clinical trials

Photo of Jennifer Hollands, PhD Jennifer Hollands, PhD Government and Academic Liaison, Cell Therapies

15:30-15:45 | Commercialization

Advancing cutting-edge therapies from bench-to-bedside

Photo of Eytan Abraham Eytan Abraham VP, Business head of Cell, Gene and Nucleic Acids franchises, Resilience

15:45-16:00 | Operation Excellence

From Benchtop to Patient -Manufacturing Considerations for Clinical Development of Advanced Therapeutics

Photo of Ritu Singla Ritu Singla Project Manager, Fortrea

16:00-16:30 | Panel Discussion

Advancing CGT trial ecosystem in APAC